2024 Pitchers
Find out more about the projects presented at MedFIT 2024:
The Award for the most Innovative Start-up goes to:
HEMERION THERAPEUTICS
Hemerion Therapeutics caught the eye at the Start-up Slams with its transformative approach to cancer treatment.
“Taking part in MedFIT and BioFIT was an enriching and stimulating experience, both in terms of presenting our project and exchanging ideas with key players in the ecosystem. Winning this award is recognition of our team’s work and our commitment to transforming the way cancer patients are cared for. This award strengthens our determination to take our mission even further.” Maximilien Vermandel, CEO, Hemerion Therapeutics
They pitched at MedFIT 2024:
ARTIFICIAL INTELLIGENCE 
INTA: In vitro diagnostics | Traumatic Brain Injuries | Deep tech
REMOTION: Virtual Rehabilitation | Tele Rehabilitation | AI Biofeedback
BIEL GLASSES: Low vision | Artificial intelligence | Assistive-technology
ASSISTIVE TECHNOLOGY
LIFEBLOOM: Walk assistance | Gait rehabilitation | Handicap Compensation
AXOMOVE: Digital clinic | Telerehabilitation | Musculoskeletal disorders
PRECISION MEDECINE / PERSONALISED TREATMENT
ABBATIALABS: Precision Medicine | Combination Product | Dose Individualisation
CLEAR.BIO: Precision Nutrition | Digital Therapeutics | Digital Dietitian
OPTIRXLAB: CT radiation dose | Monte carlo calculation | Optimisation
ONCOLOGY
ACTIPULSE NEUROSCIENCE: Blood-Brain Barrier | Non-Invasive Neuromodulation | CNS Drug Delivery
FETCH: Precision medicine | Circulating tumour cells | Oncology
HEMERION THERAPEUTICS: Oncology | Neurosurgery | Combination product
MONITORING
BRAINDEX: Anesthesia | Neuro-complications | Elderly
CORTEX MACHINA SRL: Brain to computer (BCI) | EEG | Medical Wearable
QUANTLIGHT: IVD | Bloodtesting | TherapeuticDrugMonitoring
SURGERY
PFFI: Spine | Flexible Surgical Implant | Inovative Carbon composite
SURGITEC ROBOTICS: Medtech | Surgical Robotics | Bone Surgery
SURGERIX: Microsurgery | Image guided surgery | Minimally invasive surgery
SUSTAINABILITY
FLOWBEAMS: Needlefree | Sustainability | Healthcare innovation
VOLTIFY: Deeptech | Energy | Hardware
IMPLANTABLE
OPEN STENT SOLUTION: Transcatheter valve replacement | Ribbon valve technology | Mitral & Tricuspid regurgitation
CORQUEST MEDTECH: Cardiology | Mitral | Transcatheter
LATTICE MEDICAL:Breast Reconstruction | Resorbable implant | 3D-Printed
MEDICAL DEVICES
PLAS-FREE LTD (BLOOD): Bleeding | Trauma | Hemorrhage
BARTHECO BV: Valeb | Cervical precancer | Cone biopsy
The Award for the most Promising Technology goes to:
SATT AQUITAINE
SATT Aquitaine was recognised at the Collaborative and Licensing Opportunity Presentations for its pioneering work in medtech partnerships.
They pitched at MedFIT 2024:
BIOASTER: Rapid diagnostic test | Multiplexing | Differential diagnosis
SATT SAYENS – METHYLSCAN: AI | Lung cancer | Blood test 
SATT SAYENS – ORINOVA: Gold nanoparticlesp | Bitherapy | Glioblastoma
IRCCS OSPEDALE GALEAZZI – SANT’AMBROGIO: miRNA | In Vitro Diagnostics | Osteoporosis
IRCCS SAN RAFFAELE ROMA – CONN&SENS: Functional Evaluation | Digital twin of motor process | Personalisation of care
SATT AQUITAINE: Delivery device | Cementoplasty | Interventional Radiology
SATT LUTECH – OS & DENTINE INJECTABLE: Biomaterial | Bone | Dentin
SATT LUTECH – MIMETUBE: Biomaterial | 3D cell culture | Tissue Engineering
CAREFUL SYSTEMS LIMITED: Digital health | Clinical Collaboration | Productivity
SCREENTEC OY: Medical Electrodes | Sustainable Materials | Disposables
EUROPEAN INSTITUTE OF ONCOLOGY (IEO) – PETSIGN: Breast cancer | Multigene signature | Cancer Prognosis
EUROPEAN INSTITUTE OF ONCOLOGY (IEO) – PROSIBLAD: Prognostic signature | Bladder cancer | Disease progression and recurrence
Jury members
Yves Bayon, Distinguished Scientist, Bakken Research Center, Medtronic
Frank Bulens, Partner, Imec.xpand
Lynn Coorevits, Digital Health Innovation Manager, imec
Tristan Debove, Business Angel, Angels Santé
Victor Evian, BioMedTech Analyst, Truffle Capital
Thom Frielink, Associate, Curie Capital
Peter Haasjes, Director, NextGen Ventures
Ulf Hengstmann, Digital Lead Medical Affairs & Pharmacovigilance, Bayer
Elizabeth Jennings, Managing Partner, Venture Atlas Labs
Tom Kerssemakers, Technology Assessment & Strategy Analyst, NLC Health Ventures
Antoine de Lachaux, Head of Unit – Life Sciences and Biotech, European Investment Bank
James Mayer, Partner, CABHI Ventures
Filip Pintelon, Investment Partner Health, Capricorn Partners
Robin Pumo, Analyst, Turenne Capital
Hema Purohit, Strategic Advisor & CTO Healthcare, Microsoft
Esther Rodijk, Impact Director TTT MedTech, Novel-T
Lena-Sophie Schütter, Investment Manager, High-Tech Gründerfonds
Georges Syrmalis, CEO, BioScience Equity
Etienne Vervaecke, General Manager, Eurasanté
Stig Visti Andersen, Co-Founder, VentriJect
Sponsors
- 2024 Contributing sponsor
- 2024 Contributing sponsor
- 2023 Contributing sponsor, 2024 Contributing sponsor
- 2022 Contributing sponsor, 2023 Contributing sponsor, 2024 Contributing sponsor
Continue your tour
Contact
Yingjie Weng
- Business Development Manager
- yweng@eurasante.com
- +33 (0)3 59 39 01 89
